The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R5
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices Contents     SUMMARY   1     INTRODUCTION   2     THE CARRYOVER ISSUE IN SECTION 317 EXPENDITURES   5     THE IMPACT OF THE STATE CHILDREN'S HEALTH INSURANCE PROGRAM   7     NEXT STEPS   9     REFERENCES   11     NOTES   12     APPENDIXES   14  Table 1   Annual Awards and Expenditures of Section 317 Direct Assistance (DA Vaccine Purchase Funds (in millions),   15  Table 2   Annual Awards and Expenditures of Section 317 Financial Assistance (FA) Immunization Program Funds (in millions),   16  Figure 1   Amount of New Funding Awarded as Section 317 Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,   17  Figure 2   Amount of Total Annual Awards of Section 317 Funds, Direct Assistance (DA) and Financial Assistance (FA), 1990–1999,   17  Figure 3   Section 317 Grant Allocations from CDC to State and Local Immunization Programs, 1988–1999,   18     COMMITTEE BIOGRAPHIES   19